StudyOS

Acquired

AI-powered data platform to empower study teams to automate access and oversight of their study

StudyOS was founded in 2021, is headquartered in Los Angeles, United States, lists 11–50 employees, and has $120K in recorded funding across 1 round.

Employees
11–50
Founded
2021
Business Model
B2B
Website
studyos.co
Total Funding
$120K
Last Round
$120K SeedJul 2021
Rounds
1
Acquisition Date
Nov 2025

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

studyOS is building the data platform for clinical trials. The company provides AI-powered Clinical Trial Agents that automate the centralizing, analyzing, and visualizing of clinical trial data to help keep patients safe, ensure study protocols are followed, and bring drugs to market faster. Its agentic AI assistant, Ash, allows clinical research teams to ask natural language questions about trial data — surfacing issues in seconds rather than hours of manual review. The platform consolidates disparate trial data sources into a single continuously updated interface, enabling near-real-time automated data checks aligned with ICH E6(R3) guidelines for risk-based quality management.

Summary

StudyOS is a Healthcare company based in Los Angeles, United States, founded in 2021. It lists 11–50 employees. It has raised $120K in total across 1 round, most recently a $120K Seed round in Jul 2021. Investors include Techstars.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionNov 2025

Sign up to see all 2 events

Funding: Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Neuralink

Neuralink develops investigational implantable brain-computer interfaces that help people with pa...

Fremont, United States201–500Biotech, Healthcare
Series ETotal funding$1.2BJun 2025
Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
TempusIPO

Tempus is a technology company focused on collecting and analyzing large volumes of molecular and...

Chicago, United States1001–5000Artificial Intelligence, Biotech
Series G+Total funding$960.0MOct 2021
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

StudyOS on Indexed.vc
<a href="https://indexed.vc/companies/studyos"><img src="https://indexed.vc/api/badge/company/studyos" alt="StudyOS on Indexed.vc" width="260" height="76" /></a>